Sugiyama Souta, Uno Yasuhiro, Amano Tomoko, Kitazawa Takio, Teraoka Hiroki
School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, Hokkaido 069-8501, Japan.
Shin Nippon Biomedical Laboratories, Ltd., Kainan, Wakayama 642-0017, Japan.
J Vet Med Sci. 2019 Jul 11;81(7):983-985. doi: 10.1292/jvms.19-0107. Epub 2019 May 21.
Knowledge of genetic polymorphisms of cytochrome P450 (CYP), the most important xenobiotic metabolizing enzyme, is very limited in cats. Preliminarily, we investigated genetic polymorphisms in CYP2A13, one of the major CYP isoforms in the liver and lung. Four synonymous and three non-synonymous polymorphic variants were identified in feline CYP2A13 in domestic cats in Japan, without an obvious major type. Metabolic parameters, Km and Vmax, of coumarin hydroxylation of CYP2A13 were shown to range within two times for the identified non-synonymous polymorphic variants by using heterologous coexpression system in Escherichia coli. The results confirmed the polymorphic nature of CYP2A13 as a basis for effective application of medicines and prevention of adverse reactions in treatment of domestic cats.
细胞色素P450(CYP)是最重要的外源性物质代谢酶,目前对猫体内该酶基因多态性的了解非常有限。我们初步研究了肝脏和肺脏中主要的CYP同工型之一CYP2A13的基因多态性。在日本家猫的猫CYP2A13中鉴定出四个同义多态性变体和三个非同义多态性变体,没有明显的主要类型。通过在大肠杆菌中使用异源共表达系统,已显示出所鉴定的非同义多态性变体的CYP2A13香豆素羟基化代谢参数Km和Vmax在两倍范围内。结果证实了CYP2A13的多态性本质,为家猫治疗中药物的有效应用和不良反应的预防奠定了基础。